Psykey, Inc. (CEOS)
USD 0.03
(4.52%)
USD 0.03
(4.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.32 Million USD | -165.98% |
| 2022 | -497.76 Thousand USD | -44.82% |
| 2021 | -343.69 Thousand USD | 0.0% |
| 2020 | - USD | 100.0% |
| 2019 | -4360.00 USD | -526.44% |
| 2018 | -696.00 USD | 0.0% |
| 2016 | -602 Thousand USD | 65.05% |
| 2015 | -1.72 Million USD | -20.97% |
| 2014 | -1.42 Million USD | 0.0% |
| 2007 | -9.3 Million USD | 16.33% |
| 2006 | -11.11 Million USD | -43038.86% |
| 2005 | -25.77 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q4 | -763.77 Thousand USD | -187.2% |
| 2023 FY | -1.32 Million USD | -165.98% |
| 2023 Q3 | -265.93 Thousand USD | -49.18% |
| 2023 Q1 | -115.97 Thousand USD | 17.58% |
| 2023 Q2 | -178.26 Thousand USD | -53.72% |
| 2022 FY | -497.76 Thousand USD | -44.82% |
| 2022 Q3 | -123.73 Thousand USD | -5.33% |
| 2022 Q4 | -140.71 Thousand USD | -13.72% |
| 2022 Q1 | -115.84 Thousand USD | 59.95% |
| 2022 Q2 | -117.47 Thousand USD | -1.41% |
| 2021 Q4 | -289.26 Thousand USD | -949.17% |
| 2021 FY | -343.69 Thousand USD | 0.0% |
| 2021 Q1 | -12.1 Thousand USD | 0.0% |
| 2021 Q2 | -14.76 Thousand USD | -21.97% |
| 2021 Q3 | -27.57 Thousand USD | -86.8% |
| 2020 FY | - USD | 100.0% |
| 2019 FY | -4360.00 USD | -526.44% |
| 2018 FY | -696.00 USD | 0.0% |
| 2016 FY | -602 Thousand USD | 65.05% |
| 2015 FY | -1.72 Million USD | -20.97% |
| 2014 FY | -1.42 Million USD | 0.0% |
| 2008 Q2 | -515.22 Thousand USD | 43.67% |
| 2008 Q3 | -2.28 Million USD | -342.99% |
| 2008 Q1 | -914.6 Thousand USD | 29.74% |
| 2007 Q2 | -2.72 Million USD | -8.61% |
| 2007 Q3 | -2.76 Million USD | -1.49% |
| 2007 Q1 | -2.5 Million USD | 28.77% |
| 2007 Q4 | -1.3 Million USD | 52.93% |
| 2007 FY | -9.3 Million USD | 16.33% |
| 2006 Q3 | -1.89 Million USD | 50.59% |
| 2006 FY | -11.11 Million USD | -43038.86% |
| 2006 Q4 | -3.52 Million USD | -85.9% |
| 2006 Q1 | -1.81 Million USD | 0.0% |
| 2006 Q2 | -3.83 Million USD | -110.9% |
| 2005 FY | -25.77 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -42.838% |
| Ansell Limited | 76.5 Million USD | 101.731% |
| Ansell Limited | 76.5 Million USD | 101.731% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 105.453% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 18.788% |
| ConvaTec Group Plc | 130.3 Million USD | 101.016% |
| ConvaTec Group Plc | 130.3 Million USD | 101.016% |
| Encision Inc. | -691.78 Thousand USD | -91.382% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -833.602% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -464.907% |
| Innovative MedTech Inc. | -7.93 Million USD | 83.323% |
| LifePoint, Inc. | -15.23 Million USD | 91.308% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 80.562% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -179.315% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -382.409% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -188.425% |
| SmileDirectClub, Inc. | -86.4 Million USD | 98.468% |
| Sector 10, Inc. | 7036.00 USD | 18916.814% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.066% |
| SheerVision, Inc. | -71.37 Thousand USD | -1754.897% |
| United Health Products, Inc. | -2.62 Million USD | 49.53% |
| Vasamed, Inc. | -4.88 Million USD | 72.915% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 44.569% |
| Yubo International Biotech Limited | -1.2 Million USD | -9.893% |